Impact of smoking status on long-term mortality in patients with acute myocardial infarction.

BACKGROUND Cessation of smoking after a cardiovascular event has been shown in Western countries to have a beneficial effect on clinical events during long-term follow-up. However, knowledge of the effect of smoking status after acute myocardial infarction (AMI) on the long-term mortality based on a large-scale sample is still limited in Japan. METHODS AND RESULTS In the present study 2,579 AMI patients were enrolled in the Osaka Acute Coronary Insufficiency Study (OACIS) between April 1998 and March 2003. Smoking status was assessed at baseline and 3 months after hospital discharge by mailed questionnaire. Patients were divided into nonsmokers (n=823), former smokers (those who had stopped smoking before AMI onset, n=332), quitters (those who stopped smoking after AMI onset, n=1,056), and persistent smokers (those who smoked before and after AMI, n=368). Quitters had lower long-term mortality rates than persistent smokers (3.0% vs 5.2%; log rank, p=0.032). Multivariate Cox regression analysis revealed that smoking cessation was independently associated with a reduction in risk of long-term mortality (hazard ratio, 0.39; 95% confidence interval, 0.20-0.77). CONCLUSIONS Patients who continue to smoke after AMI are at greater risk for death than patients who quit smoking. Cessation of smoking benefits the long-term prognosis in patients with AMI.

[1]  D. Webb,et al.  Endothelial dysfunction, impaired endogenous fibrinolysis, and cigarette smoking: a mechanism for arterial thrombosis and myocardial infarction. , 1999, Circulation.

[2]  Y. Miyake.  Risk factors for non-fatal acute myocardial infarction in middle-aged and older Japanese. Fukuoka Heart Study Group. , 2000, Japanese circulation journal.

[3]  J. Perkins,et al.  Smoking and myocardial infarction: secondary prevention. , 1985, Postgraduate medical journal.

[4]  M. Weinstein,et al.  Cost-effectiveness of a smoking cessation program after myocardial infarction. , 1993, Journal of the American College of Cardiology.

[5]  M. Billie,et al.  Cardiac Arrhythmias Following Intravenous Nicotine: Experimental Study in Dogs , 1997, Journal of cardiovascular pharmacology and therapeutics.

[6]  R. Hone,et al.  Letter: Methicillin-resistant Staphylococcus aureus. , 1974, Lancet.

[7]  L. Wilhelmsen,et al.  SMOKING AND MYOCARDIAL INFARCTION , 1975, The Lancet.

[8]  C. Mulrow,et al.  Use of lipid lowering drugs for primary prevention of coronary heart disease: meta-analysis of randomised trials , 2000, BMJ : British Medical Journal.

[9]  L. Wilhelmsen,et al.  Fibrinogen as a risk factor for stroke and myocardial infarction. , 1984, The New England journal of medicine.

[10]  R. Mulcahy,et al.  Factors affecting the 5 year survival rate of men following acute coronary heart disease. , 1977, American heart journal.

[11]  T. Dawber,et al.  The influence of cigarette smoking on prognosis after a first myocardial infarction. A report from the Framingham study. , 1978, Journal of chronic diseases.

[12]  J. Deanfield,et al.  Direct effects of smoking on the heart: silent ischemic disturbances of coronary flow. , 1986, The American journal of cardiology.

[13]  J. Critchley,et al.  Mortality risk reduction associated with smoking cessation in patients with coronary heart disease: a systematic review. , 2003, JAMA.

[14]  Y. Miyake.  Risk Factors for Non-Fatal Acute Myocardial Infarction in Middle-Aged and Older Japanese , 2000 .

[15]  Nicholas Smith,et al.  Smoking Status and Risk for Recurrent Coronary Events after Myocardial Infarction , 2002, Annals of Internal Medicine.

[16]  P. Quist-Paulsen,et al.  Randomised controlled trial of smoking cessation intervention after admission for coronary heart disease , 2003, BMJ : British Medical Journal.

[17]  E. Gilpin,et al.  Smoking status at the time of acute myocardial infarction and subsequent prognosis. , 1985, American heart journal.

[18]  P. Thompson,et al.  A randomized controlled trial of smoking cessation counseling after myocardial infarction. , 2000, Preventive medicine.

[19]  R. Kronmal,et al.  Beneficial six-year outcome of smoking cessation in older men and women with coronary artery disease. Results from the CASS registry. , 1988, The New England journal of medicine.

[20]  N Freemantle,et al.  beta Blockade after myocardial infarction: systematic review and meta regression analysis. , 1999, BMJ.

[21]  Y. Matsuzawa,et al.  Large scale cohort study of the relationship between serum cholesterol concentration and coronary events with low-dose simvastatin therapy in Japanese patients with hypercholesterolemia. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[22]  R. Yamada,et al.  Identification of 187 single nucleotide polymorphisms (SNPs) among 41 candidate genes for ischemic heart disease in the Japanese population , 2000, Human Genetics.

[23]  Salim Yusuf,et al.  Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients , 2000, The Lancet.

[24]  S. Johansson,et al.  Cessation of smoking after myocardial infarction. Effects on mortality after 10 years. , 1983, British heart journal.

[25]  Y. Ohnishi,et al.  Impact of high-sensitivity C-reactive protein on predicting long-term mortality of acute myocardial infarction. , 2003, The American journal of cardiology.

[26]  M. J. van der Vlugt,et al.  Characteristics of smokers and long-term changes in smoking behavior in consecutive patients with myocardial infarction. , 2000, Preventive medicine.

[27]  H. Fujiwara.  Anti-smoking declaration: a message from the Japanese Circulation Society. , 2003, Circulation journal : official journal of the Japanese Circulation Society.

[28]  J. Salonen.  Stopping smoking and long-term mortality after acute myocardial infarction. , 1980, British heart journal.

[29]  A. LaCroix,et al.  Smoking and mortality among older men and women in three communities. , 1991, The New England journal of medicine.

[30]  D. Cook,et al.  Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies. , 2000, Archives of internal medicine.

[31]  Y. Ohnishi,et al.  Prevalence of Helicobacter pylori infection and its link to coronary risk factors in Japanese patients with acute myocardial infarction. , 2002, Circulation journal : official journal of the Japanese Circulation Society.

[32]  Diane C. Thompson,et al.  The validity of self-reported smoking: a review and meta-analysis. , 1994, American journal of public health.

[33]  S. Renaud,et al.  Platelet function after cigarette smoking in relation to nicotine and carbon monoxide , 1984, Clinical pharmacology and therapeutics.

[34]  H. Scheffer,et al.  RAPID SCREENING FOR DELTA-F508 DELETION IN CYSTIC-FIBROSIS , 1989 .

[35]  H. Yasuda,et al.  Beneficial effect of stopping smoking on future cardiac events in male smokers with previous myocardial infarction. , 1992, Japanese circulation journal.

[36]  Yusuke Nakamura,et al.  Functional variation in LGALS2 confers risk of myocardial infarction and regulates lymphotoxin-α secretion in vitro , 2004, Nature.

[37]  M. Phelps,et al.  Effect of acute and long-term smoking on myocardial blood flow and flow reserve. , 1995, Circulation.

[38]  W. Kannel,et al.  Death and coronary attacks in men after giving up cigarette smoking. A report from the Framingham study. , 1974, Lancet.

[39]  Catherine Sudlow,et al.  Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients , 2002, BMJ : British Medical Journal.

[40]  F. Takatsu,et al.  Cigarette Smoking Is a Major Risk Factor for Coronary Spasm , 1993, Circulation.